Pomalidomide Plus Bortezomib Plus Low-Dose Dexamethasone Vs Bortezomib Plus Low-Dose Dexamethasone As Second-Line Treatment In Patients With Lenalidomide-Pretreated Multiple Myeloma: A Subgroup Analysis Of The Phase 3 Optimismm Trial
BLOOD(2018)
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要